IMMUNOGENE ARGINASEPEPTIDE
European patent · EP3522905 · In force
Register entry
- Publication number
- EP3522905
- Application number
- EP17786870
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Oct 6, 2017
- Published
- Aug 14, 2019
- Granted
- Sep 25, 2024
- Protection ends at the latest
- Oct 5, 2037
- Next annual fee due
- Oct 31, 2026
- IPC classes
- A61P 35/00 (2006.01)A61P 37/00 (2006.01)A61P 43/00 (2006.01)A61K 38/00 (2006.01)C12N 9/96 (2006.01)A61P 37/02 (2006.01)
- Priority
- EP 16192794 07.10.2016
- PCT application
- PCT/EP2017/075443 06.10.2017
- PCT publication
- WO2018/065563 12.04.2018
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Nov 1, 2025
Change
Published in Swissreg on 01.11.2025
- Aug 6, 2025
Change
Published in Swissreg on 06.08.2025
- Nov 20, 2024
Change
Published in Swissreg on 20.11.2024
- Nov 4, 2024
Agent entered
- Representative
- Isler & Pedrazzini AG, Postfach, 8027 Zürich
Published in Swissreg on 04.11.2024
- Sep 25, 2024
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 25.09.2024
Parties
Inventor
ANDERSEN, Mads Hald
2850 Nærum, DK
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.